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Background:  Over 40% of patients undergoing coronary artery bypass surgery (CABG) have diabetes. However, few studies have 
examined how insulin treatment status influences surgical outcomes among patients with diabetes.
methods:  All isolated CABG, CABG plus aortic valve replacement and CABG plus mitral valve repair or replacement cases performed 
in 2012 were extracted from the California CABG outcomes reporting program (CCORP) database. Patients were grouped into three 
categories: (1) No diabetes, (2) Non-Insulin treated Diabetes (NITDM), and (3) Insulin treated diabetes (ITDM). Demographic and clinical 
baseline characteristics and observed postoperative major adverse events, including 30-day mortality, stroke, deep sternal wound infection, 
prolonged ventilation, new dialysis requirement, renal failure and 30-day readmission were compared. Multivariable logistic regression 
models were developed to predict the impact of NITDM and ITDM on major postoperative adverse events.
results:  14,051 patients underwent isolated CABG or CABG plus aortic/mitral valve procedures in California during 2012. 6,700 (47.7%) 
had no diabetes, 5,165 (36.8%) were NITDM and 2,183 (15.6%) were ITDM. Compared to the non-diabetic and NITDM groups, ITDM were 
younger, more frequently female and non-white and had a higher prevalence of preoperative comorbidities (all p<0.05). ITDM patients had 
the highest operative mortality, major adverse event rates, and 30-day readmission rate (all p<0.05). After adjusting for baseline risk factors 
and surgery type compared to patients without diabetes, both NITDM and ITDM were associated with significantly increased risk of major 
adverse events (Adjusted Odds Ratio (AOR) for NITDM: 1.15, 95 % confidence interval (CI): 1.04-1.26, p=0.005; AOR for ITDM: 1.49, 95% 
CI: 1.32-1.68, p<0.0001). A subgroup comparison demonstrated a similar gradient of risk for each type of cardiac surgery.
Conclusion:  Patients with diabetes undergoing coronary artery bypass grafting have significantly increased observed and risk-adjusted 
rates of major adverse events. Patients with insulin-treated diabetes represent an especially high-risk group of patients.
